Technical Analysis for RVPH - Reviva Pharmaceuticals Holdings, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 3.12 | 0.97% | 0.03 |
RVPH closed up 2.32 percent on Monday, April 22, 2024, on 39 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 13
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Calm After Storm | Range Contraction | 0.97% | |
| Wide Bands | Range Expansion | 0.97% | |
| Lower Bollinger Band Touch | Weakness | 0.97% | |
| Oversold Stochastic | Weakness | 0.97% | |
| Calm After Storm | Range Contraction | 3.31% | |
| NR7 | Range Contraction | 3.31% | |
| Narrow Range Bar | Range Contraction | 3.31% | |
| Wide Bands | Range Expansion | 3.31% | |
| Oversold Stochastic | Weakness | 3.31% | |
| Stochastic Reached Oversold | Weakness | 3.31% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | about 2 hours ago |
| Up 3% | about 2 hours ago |
| Up 2% | about 2 hours ago |
| Down 1% | about 3 hours ago |
| Up 1% | about 3 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
Reviva Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops therapies to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases. Its lead product candidate is RP5063 for the treatment of schizophrenia, bipolar disorder, and major depressive disorder, as well as for treating pulmonary arterial hypertension and idiopathic pulmonary fibrosis. The company is based in Cupertino, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Drugs Inflammatory Diseases Schizophrenia Psychiatric Diagnosis Psychiatry Major Depressive Disorder Stage Pharmaceutical Idiopathic Pulmonary Fibrosis Pulmonary Arterial Hypertension Pulmonary Fibrosis Chloroarenes Bipolar Disorder Pulmonary Hypertension Treatment Of Schizophrenia Piperazines
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Drugs Inflammatory Diseases Schizophrenia Psychiatric Diagnosis Psychiatry Major Depressive Disorder Stage Pharmaceutical Idiopathic Pulmonary Fibrosis Pulmonary Arterial Hypertension Pulmonary Fibrosis Chloroarenes Bipolar Disorder Pulmonary Hypertension Treatment Of Schizophrenia Piperazines
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 9.2499 |
| 52 Week Low | 2.67 |
| Average Volume | 283,310 |
| 200-Day Moving Average | 4.28 |
| 50-Day Moving Average | 3.65 |
| 20-Day Moving Average | 3.50 |
| 10-Day Moving Average | 3.39 |
| Average True Range | 0.28 |
| RSI (14) | 39.39 |
| ADX | 21.14 |
| +DI | 19.83 |
| -DI | 29.07 |
| Chandelier Exit (Long, 3 ATRs) | 3.24 |
| Chandelier Exit (Short, 3 ATRs) | 3.50 |
| Upper Bollinger Bands | 4.04 |
| Lower Bollinger Band | 2.95 |
| Percent B (%b) | 0.13 |
| BandWidth | 31.08 |
| MACD Line | -0.11 |
| MACD Signal Line | -0.06 |
| MACD Histogram | -0.0522 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.39 | ||||
| Resistance 3 (R3) | 3.38 | 3.26 | 3.34 | ||
| Resistance 2 (R2) | 3.26 | 3.19 | 3.27 | 3.32 | |
| Resistance 1 (R1) | 3.18 | 3.14 | 3.22 | 3.19 | 3.31 |
| Pivot Point | 3.06 | 3.06 | 3.09 | 3.07 | 3.06 |
| Support 1 (S1) | 2.98 | 2.99 | 3.02 | 2.99 | 2.87 |
| Support 2 (S2) | 2.86 | 2.94 | 2.87 | 2.86 | |
| Support 3 (S3) | 2.78 | 2.86 | 2.84 | ||
| Support 4 (S4) | 2.79 |
